Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.5 to v3.6.6, signaling a behind-the-scenes update to the page framework rather than a content change. This is a platform-level update and does not alter visible study information.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:50.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.4 to v3.6.5, signaling a small maintenance/update. It does not change study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-08T18:36:43.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, replacing the previous v3.6.3, indicating a new version of the study page.
    Difference
    0.1%
    Check dated 2026-07-25T12:32:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:40:15.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.0 to v3.6.2, signaling a backend version update. No user-facing content or behavior was modified.
    Difference
    0.1%
    Check dated 2026-06-26T20:23:31.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Recruitment status updated to not currently enrolling participants. New navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the Intervention/Treatment heading formatting was updated along with the revision label from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:52.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.